Listed

Dare Bioscience, Inc.

DARENasdaqCIK 1401914HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$187.5k, Q2 FY2026
Operating income−$3.0m, Q2 FY2026
Net income−$3.0m, Q2 FY2026
Dare Bioscience, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1.0Revenue, Q3 FY2023, three months to 2023-09-30$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2023-11-09, accession 0001401914-23-000048.Report this figure1.8Revenue, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001401914-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$9.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$22.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$41.7k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(0.1)Revenue, Q4 FY2024, three months to 2024-12-31−$63.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$25.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(0.0)Revenue, Q2 FY2025, three months to 2025-06-30−$21.2k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001401914-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$2.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure1.0Revenue, Q4 FY2025, three months to 2025-12-31$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.2Revenue, Q1 FY2026, three months to 2026-03-31$152.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure0.2Revenue, Q2 FY2026, three months to 2026-06-30$187.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figurenot reportednot reported0.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$242.3k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure0.3Cost of revenue, Q2 FY2026, three months to 2026-06-30$319.9k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Research and development$m6.7Research and development, Q3 FY2023, three months to 2023-09-30$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure3.8Research and development, Q4 FY2023, three months to 2023-12-31$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001401914-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure3.4Research and development, Q1 FY2024, three months to 2024-03-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure4.9Research and development, Q2 FY2024, three months to 2024-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure2.7Research and development, Q3 FY2024, three months to 2024-09-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure3.3Research and development, Q4 FY2024, three months to 2024-12-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure2.3Research and development, Q1 FY2025, three months to 2025-03-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure1.4Research and development, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure1.2Research and development, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure0.6Research and development, Q4 FY2025, three months to 2025-12-31$622.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.7Research and development, Q1 FY2026, three months to 2026-03-31$660.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure0.2Research and development, Q2 FY2026, three months to 2026-06-30$242.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reported2.3Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure2.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figurenot reportednot reported2.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure2.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Operating income$m(8.4)Operating income, Q3 FY2023, three months to 2023-09-30−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure(5.2)Operating income, Q4 FY2023, three months to 2023-12-31−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001401914-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(6.0)Operating income, Q1 FY2024, three months to 2024-03-31−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure(7.4)Operating income, Q2 FY2024, three months to 2024-06-30−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure(4.7)Operating income, Q3 FY2024, three months to 2024-09-30−$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(5.4)Operating income, Q4 FY2024, three months to 2024-12-31−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(4.6)Operating income, Q1 FY2025, three months to 2025-03-31−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(3.8)Operating income, Q2 FY2025, three months to 2025-06-30−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(3.7)Operating income, Q3 FY2025, three months to 2025-09-30−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(1.5)Operating income, Q4 FY2025, three months to 2025-12-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(3.0)Operating income, Q1 FY2026, three months to 2026-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(3.0)Operating income, Q2 FY2026, three months to 2026-06-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(8.3)Net income, Q3 FY2023, three months to 2023-09-30−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure(5.1)Net income, Q4 FY2023, three months to 2023-12-31−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001401914-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(6.8)Net income, Q1 FY2024, three months to 2024-03-31−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure12.9Net income, Q2 FY2024, three months to 2024-06-30$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(4.7)Net income, Q3 FY2024, three months to 2024-09-30−$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(5.5)Net income, Q4 FY2024, three months to 2024-12-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(4.4)Net income, Q1 FY2025, three months to 2025-03-31−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(4.0)Net income, Q2 FY2025, three months to 2025-06-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(3.6)Net income, Q3 FY2025, three months to 2025-09-30−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(1.4)Net income, Q4 FY2025, three months to 2025-12-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(3.0)Net income, Q1 FY2026, three months to 2026-03-31−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(3.0)Net income, Q2 FY2026, three months to 2026-06-30−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Diluted EPS$ per share(1.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figurenot reported(0.81)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure1.52Diluted EPS, Q2 FY2024, three months to 2024-06-30$1.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure(0.55)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figurenot reported(0.50)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(0.45)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(0.28)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(0.20)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Basic EPS$ per share(1.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figurenot reported(0.81)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure1.53Basic EPS, Q2 FY2024, three months to 2024-06-30$1.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure(0.55)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figurenot reported(0.50)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(0.45)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(0.28)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figurenot reported(0.21)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(0.20)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure

Balance sheet

Cash and equivalents$12.6m, Q2 FY2026
Shareholders' equity−$560.1k, Q2 FY2026
Dare Bioscience, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m13.9Cash and equivalents, Q3 FY2023, at 2023-09-30$13.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure10.5Cash and equivalents, FY2023, at 2023-12-31$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001401914-25-000012.Report this figure3.6Cash and equivalents, Q1 FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure16.4Cash and equivalents, Q2 FY2024, at 2024-06-30$16.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure11.2Cash and equivalents, Q3 FY2024, at 2024-09-30$11.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure15.7Cash and equivalents, FY2024, at 2024-12-31$15.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001401914-26-000004.Report this figure10.3Cash and equivalents, Q1 FY2025, at 2025-03-31$10.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure5.0Cash and equivalents, Q2 FY2025, at 2025-06-30$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure23.1Cash and equivalents, Q3 FY2025, at 2025-09-30$23.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure24.7Cash and equivalents, FY2025, at 2025-12-31$24.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure18.5Cash and equivalents, Q1 FY2026, at 2026-03-31$18.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure12.6Cash and equivalents, Q2 FY2026, at 2026-06-30$12.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Current assets$m22.4Current assets, Q3 FY2023, at 2023-09-30$22.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001401914-23-000048.Report this figure17.5Current assets, FY2023, at 2023-12-31$17.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001401914-25-000012.Report this figure10.0Current assets, Q1 FY2024, at 2024-03-31$10.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001401914-24-000033.Report this figure20.8Current assets, Q2 FY2024, at 2024-06-30$20.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001401914-24-000038.Report this figure14.9Current assets, Q3 FY2024, at 2024-09-30$14.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure18.4Current assets, FY2024, at 2024-12-31$18.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001401914-26-000004.Report this figure11.8Current assets, Q1 FY2025, at 2025-03-31$11.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure6.6Current assets, Q2 FY2025, at 2025-06-30$6.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure25.0Current assets, Q3 FY2025, at 2025-09-30$25.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure27.1Current assets, FY2025, at 2025-12-31$27.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure21.7Current assets, Q1 FY2026, at 2026-03-31$21.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure16.7Current assets, Q2 FY2026, at 2026-06-30$16.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Total assets$m25.1Total assets, Q3 FY2023, at 2023-09-30$25.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001401914-23-000048.Report this figure21.3Total assets, FY2023, at 2023-12-31$21.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001401914-25-000012.Report this figure13.0Total assets, Q1 FY2024, at 2024-03-31$13.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001401914-24-000033.Report this figure23.6Total assets, Q2 FY2024, at 2024-06-30$23.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001401914-24-000038.Report this figure18.1Total assets, Q3 FY2024, at 2024-09-30$18.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure22.1Total assets, FY2024, at 2024-12-31$22.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001401914-26-000004.Report this figure18.6Total assets, Q1 FY2025, at 2025-03-31$18.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure13.0Total assets, Q2 FY2025, at 2025-06-30$13.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure30.7Total assets, Q3 FY2025, at 2025-09-30$30.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure32.5Total assets, FY2025, at 2025-12-31$32.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure27.8Total assets, Q1 FY2026, at 2026-03-31$27.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure22.4Total assets, Q2 FY2026, at 2026-06-30$22.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Current liabilities$m26.3Current liabilities, Q3 FY2023, at 2023-09-30$26.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001401914-23-000048.Report this figure20.5Current liabilities, FY2023, at 2023-12-31$20.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001401914-25-000012.Report this figure17.7Current liabilities, Q1 FY2024, at 2024-03-31$17.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001401914-24-000033.Report this figure14.6Current liabilities, Q2 FY2024, at 2024-06-30$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001401914-24-000038.Report this figure13.2Current liabilities, Q3 FY2024, at 2024-09-30$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure21.6Current liabilities, FY2024, at 2024-12-31$21.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001401914-26-000004.Report this figure21.2Current liabilities, Q1 FY2025, at 2025-03-31$21.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure19.2Current liabilities, Q2 FY2025, at 2025-06-30$19.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure21.2Current liabilities, Q3 FY2025, at 2025-09-30$21.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure23.7Current liabilities, FY2025, at 2025-12-31$23.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure21.1Current liabilities, Q1 FY2026, at 2026-03-31$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure16.9Current liabilities, Q2 FY2026, at 2026-06-30$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Total liabilities$m27.3Total liabilities, Q3 FY2023, at 2023-09-30$27.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001401914-23-000048.Report this figure26.3Total liabilities, FY2023, at 2023-12-31$26.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001401914-25-000012.Report this figure24.0Total liabilities, Q1 FY2024, at 2024-03-31$24.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001401914-24-000033.Report this figure20.9Total liabilities, Q2 FY2024, at 2024-06-30$20.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001401914-24-000038.Report this figure19.5Total liabilities, Q3 FY2024, at 2024-09-30$19.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure28.1Total liabilities, FY2024, at 2024-12-31$28.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001401914-26-000004.Report this figure28.2Total liabilities, Q1 FY2025, at 2025-03-31$28.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure25.7Total liabilities, Q2 FY2025, at 2025-06-30$25.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure27.9Total liabilities, Q3 FY2025, at 2025-09-30$27.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure29.6Total liabilities, FY2025, at 2025-12-31$29.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure27.1Total liabilities, Q1 FY2026, at 2026-03-31$27.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure22.9Total liabilities, Q2 FY2026, at 2026-06-30$22.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2024, at 2024-12-31$4.1k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure0.1Current portion of debt, Q1 FY2025, at 2025-03-31$91.9k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure0.2Current portion of debt, Q2 FY2025, at 2025-06-30$188.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure0.0Current portion of debt, Q3 FY2025, at 2025-09-30$10.5k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figurenot reportednot reportednot reported
Shareholders' equity$m(2.3)Shareholders' equity, Q3 FY2023, at 2023-09-30−$2.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure(5.0)Shareholders' equity, FY2023, at 2023-12-31−$5.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001401914-26-000004.Report this figure(11.0)Shareholders' equity, Q1 FY2024, at 2024-03-31−$11.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure2.7Shareholders' equity, Q2 FY2024, at 2024-06-30$2.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(1.5)Shareholders' equity, Q3 FY2024, at 2024-09-30−$1.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure(6.0)Shareholders' equity, FY2024, at 2024-12-31−$6.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(9.6)Shareholders' equity, Q1 FY2025, at 2025-03-31−$9.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(12.7)Shareholders' equity, Q2 FY2025, at 2025-06-30−$12.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure2.9Shareholders' equity, Q3 FY2025, at 2025-09-30$2.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure2.8Shareholders' equity, FY2025, at 2025-12-31$2.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure0.7Shareholders' equity, Q1 FY2026, at 2026-03-31$734.5k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure(0.6)Shareholders' equity, Q2 FY2026, at 2026-06-30−$560.1k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure

Cash flow

Operating cash flow−$6.8m, Q2 FY2026
Capital expenditure$80.6k, Q2 FY2026
Dare Bioscience, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001401914-24-000041. Derived: 9-month figure less the 6-month figure.Report this figure(8.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001401914-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(6.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure12.9Operating cash flow, Q2 FY2024, three months to 2024-06-30$12.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001401914-25-000044. Derived: 6-month figure less the 3-month figure.Report this figure(5.9)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001401914-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure5.3Operating cash flow, Q4 FY2024, three months to 2024-12-31$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(5.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(5.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001401914-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure(0.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$442.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001401914-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure1.4Operating cash flow, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(5.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(6.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001401914-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$22.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001401914-24-000041. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$607.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001401914-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$7.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$285.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001401914-25-000044. Derived: 6-month figure less the 3-month figure.Report this figure(0.3)Capital expenditure, Q3 FY2024, three months to 2024-09-30−$282.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001401914-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$562.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$157.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure(0.2)Capital expenditure, Q2 FY2025, three months to 2025-06-30−$153.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001401914-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$174.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001401914-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$206.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001401914-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$80.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001401914-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)14.89m, Q2 FY2026
Dare Bioscience, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares84.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3084,822,516 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001401914-23-000048.Report this figure85.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3185,517,540 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001401914-24-000033.Report this figure7.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-307,200,260 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001401914-24-000038.Report this figure7.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-307,587,637 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001401914-24-000041.Report this figure8.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-318,376,189 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001401914-25-000022.Report this figure8.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-308,476,231 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001401914-25-000044.Report this figure8.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-308,534,433 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure8.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,759,053 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure8.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,871,155 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure12.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3012,755,112 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001401914-25-000050.Report this figure14.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3114,522,835 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001401914-26-000026.Report this figure14.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3014,889,832 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure

Shares outstanding: 15.29mShares outstanding, period not labelled, at 2026-08-1215,289,502 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001401914-26-000043.Report this figure at Aug 12, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.